Abstract
The molecular basis underlying the specificity of alloreactive T cells for peptide–major histocompatibility complex ligands has been elusive. Here we describe a screen of 60 I-Ek-alloreactive T cells and 83 naturally processed peptides that identified 9 reactive T cells. Three of the T cells responded to multiple, distinct peptides that shared no sequence homology. These T cells recognized each peptide–major histocompatibility complex ligand specifically and used a distinct constellation of I-Ek contact residues for each interaction. Our studies show that alloreactive T cells have a 'germline-encoded' capacity to recognize multiple, distinct ligands and thus show 'polyspecificity', not degeneracy. Our findings help to explain the high frequency of alloreactive T cells and provide insight into the nature of T cell specificity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Sherman, L.A. & Chattopadhyay, S. The molecular basis of allorecognition. Annu. Rev. Immunol. 11, 385–402 (1993).
Csencsits, K.L. & Bishop, D.K. Contrasting alloreactive CD4+ and CD8+ T Cells: There's more to it than MHC restriction. Am. J. Transplant. 3, 107–115 (2003).
Suchin, E.J. et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166, 973–981 (2001).
Crumpacker, D.B., Alexander, J., Cresswell, P. & Engelhard, V.H. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J. Immunol. 148, 3004–3011 (1992).
Demotz, S. et al. Self peptide requirement for class II major histocompatibility complex allorecognition. Proc. Natl. Acad. Sci. USA 88, 8730–8734 (1991).
Guimezanes, A. et al. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence. Eur. J. Immunol. 31, 421–432 (2001).
Heath, W.R., Kane, K.P., Mescher, M.F. & Sherman, L.A. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88, 5101–5105 (1991).
Heath, W.R. & Sherman, L.A. Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur. J. Immunol. 21, 153–159 (1991).
Hong, S.C. et al. The orientation of a T cell receptor to its MHC class II:peptide ligands. J. Immunol. 159, 4395–4402 (1997).
Malarkannan, S., Afkarian, M. & Shastri, N. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182, 1739–1750 (1995).
Matis, L.A., Sorger, S.B., McElligott, D.L., Fink, P.J. & Hedrick, S.M. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell 51, 59–69 (1987).
Mendiratta, S.K. et al. Peptide dependency of alloreactive CD4+ T cell responses. Int. Immunol. 11, 351–360 (1999).
Obst, R., Munz, C., Stevanovic, S. & Rammensee, H.G. Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire. Eur. J. Immunol. 28, 2432–2443 (1998).
Reinherz, E.L. et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286, 1913–1921 (1999).
Sayegh, M.H. et al. Allograft rejection in a new allospecific CD4+ TCR transgenic mouse. Am. J. Transplant. 3, 381–389 (2003).
Weber, D.A. et al. Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules. J. Immunol. 154, 5153–5164 (1995).
Basu, D., Horvath, S., Matsumoto, I., Fremont, D.H. & Allen, P.M. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J. Immunol. 164, 5788–5796 (2000).
Basu, D., Horvath, S., O'Mara, L., Donermeyer, D. & Allen, P.M. Two MHC surface amino acid differences distinguish foreign peptide recognition from autoantigen specificity. J. Immunol. 166, 4005–4011 (2001).
Huseby, E.S., Crawford, F., White, J., Kappler, J. & Marrack, P. Negative selection imparts peptide specificity to the mature T cell repertoire. Proc. Natl. Acad. Sci. USA 100, 11565–11570 (2003).
Panina-Bordignon, P., Corradin, G., Roosnek, E., Sette, A. & Lanzavecchia, A. Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science 252, 1548–1550 (1991).
Alexander-Miller, M.A., Burke, K., Koszinowski, U.H., Hansen, T.H. & Connolly, J.M. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J. Immunol. 151, 1–10 (1993).
Reiser, J.B. et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol. 1, 291–297 (2000).
Udaka, K., Tsomides, T.J. & Eisen, H.N. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69, 989–998 (1992).
Eisen, H.N. Specificity and degeneracy in antigen recognition: yin and yang in the immune system. Annu. Rev. Immunol. 19, 1–21 (2001).
Matzinger, P. & Bevan, M.J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29, 1–5 (1977).
Wang, J. & Reinherz, E.L. Structural basis of cell-cell interactions in the immune system. Curr. Opin. Struct. Biol. 10, 656–661 (2000).
Housset, D. & Malissen, B. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Trends Immunol. 24, 429–437 (2003).
Suri, A. et al. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J. Immunol. 168, 1235–1243 (2002).
Felix, N.J. et al. I-Ep-bound self-peptides: identification, characterization, and role in alloreactivity. J. Immunol. 176, 1062–1071 (2006).
Altman, J.D., Reay, P.A. & Davis, M.M. Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 90, 10330–10334 (1993).
Marrack, P., Ignatowicz, L., Kappler, J.W., Boymel, J. & Freed, J.H. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178, 2173–2183 (1993).
Ehrich, E.W. et al. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J. Exp. Med. 178, 713–722 (1993).
Evavold, B.D., Williams, S.G., Hsu, B.L., Buus, S. & Allen, P.M. Complete dissection of the Hb(64–76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 148, 347–353 (1992).
Fremont, D.H., Hendrickson, W.A., Marrack, P. & Kappler, J. Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001–1004 (1996).
Kersh, G.J. et al. Structural and functional consequences of altering a peptide MHC anchor residue. J. Immunol. 166, 3345–3354 (2001).
Krogsgaard, M. et al. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 434, 238–243 (2005).
Daniel, C., Horvath, S. & Allen, P.M. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 8, 543–552 (1998).
Schild, H. et al. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. Int. Immunol. 7, 1957–1965 (1995).
Rudolph, M.G., Stanfield, R.L. & Wilson, I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24, 419–466 (2006).
Reiser, J.B. et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4, 241–247 (2003).
Huseby, E.S., Crawford, F., White, J., Marrack, P. & Kappler, J.W. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide. Nat. Immunol. 7, 1191–1199 (2006).
Vidal, K., Daniel, C., Hill, M., Littman, D.R. & Allen, P.M. Differential requirements for CD4 in TCR-ligand interactions. J. Immunol. 163, 4811–4818 (1999).
Masteller, E.L. et al. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 171, 5587–5595 (2003).
Jerne, N.K. The somatic generation of immune recognition. Eur. J. Immunol. 1, 1–9 (1971).
Donermeyer, D.L., Weber, K.S., Kranz, D.M. & Allen, P.M. The study of high-affinity TCRs reveal duality in T cell recognition of antigen: specificity and degeneracy. J. Immunol. 177, 6911–6919 (2006).
Marrack, P. et al. Major histocompatibility complex proteins and TCRs: do they really go together like a horse and carriage? J. Immunol. 167, 617–621 (2001).
Obst, R., Netuschil, N., Klopfer, K., Stevanovic, S. & Rammensee, H.G. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J. Exp. Med. 191, 805–812 (2000).
Luz, J.G. et al. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing Vβ interactions. J. Exp. Med. 195, 1175–1186 (2002).
Bluestone, J.A., Kaliyaperumal, A., Jameson, S., Miller, S. & Dick, R., II. Peptide-induced changes in class I heavy chains alter allorecognition. J. Immunol. 151, 3943–3953 (1993).
Baker, F.J., Lee, M., Chien, Y.-h. & Davis, M.M. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl. Acad. Sci. USA 99, 9374–9379 (2002).
Acknowledgements
We thank M. Davis for the I-Ek mutant CHO cell lines, D. Kreamalmeyer for maintenance of the mouse colony, J. Smith for assistance in the preparation of the manuscript, and T. Hansen, E. Unanue and S. Weber for critical review of the manuscript. Supported by the National Centers for Research Resources of the National Institutes of Health (2P41RR00954, for mass spectrometry measurements).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Identification of allostimulatory peptide binding registers. (PDF 579 kb)
Supplementary Table 1
Naturally processed and presented I-Ek bound peptides. (PDF 73 kb)
Supplementary Table 2
Multiple peptide-reactive allo-T cells interact with different MHC residues for each allostimulatory peptide. (PDF 75 kb)
Supplementary Table 3
Priming mice prior to allostimulation does not bias the TCR repertoire. (PDF 66 kb)
Rights and permissions
About this article
Cite this article
Felix, N., Donermeyer, D., Horvath, S. et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat Immunol 8, 388–397 (2007). https://doi.org/10.1038/ni1446
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1446
This article is cited by
-
Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
Scientific Reports (2021)
-
Transient increase of activated regulatory T cells early after kidney transplantation
Scientific Reports (2019)
-
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity
Nature Immunology (2016)
-
Human CD4+ effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells
Cellular & Molecular Immunology (2013)
-
A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro
Immunogenetics (2013)